Christopher C. Bond
AuthID: R-00G-SVW
1
TITLE: Impact of seizure frequency reduction on health-related quality of life among clinical trial subjects with refractory partial-onset seizures: A pooled analysis of phase III clinical trials of eslicarbazepine acetate Full Text
AUTHORS: Fulton F Velez; Christopher C Bond; Kathryn P Anastassopoulos; Xuezhe Z Wang; Rui Sousa; David Blum; Joyce A Cramer;
PUBLISHED: 2017, SOURCE: EPILEPSY & BEHAVIOR, VOLUME: 68
AUTHORS: Fulton F Velez; Christopher C Bond; Kathryn P Anastassopoulos; Xuezhe Z Wang; Rui Sousa; David Blum; Joyce A Cramer;
PUBLISHED: 2017, SOURCE: EPILEPSY & BEHAVIOR, VOLUME: 68
INDEXED IN: 
WOS
WOS2
TITLE: Severity and burden of partial-onset seizures in a phase III trial of eslicarbazepine acetate Full Text
AUTHORS: Joyce A Cramer; Fulton F Velez; Kathryn P Anastassopoulos; Christopher C Bond; Frank G Gilliam; Philippe Ryvlin; Luigi M Specchio; Xuezhe Z Wang; David Blum; Joana Moreira; Francisco Rocha;
PUBLISHED: 2015, SOURCE: EPILEPSY & BEHAVIOR, VOLUME: 53
AUTHORS: Joyce A Cramer; Fulton F Velez; Kathryn P Anastassopoulos; Christopher C Bond; Frank G Gilliam; Philippe Ryvlin; Luigi M Specchio; Xuezhe Z Wang; David Blum; Joana Moreira; Francisco Rocha;
PUBLISHED: 2015, SOURCE: EPILEPSY & BEHAVIOR, VOLUME: 53
